Understanding how brain markers relate to cannabis use in adolescents
Leveraging complementary big data methods and patient intervention designs to optimize neural markers of adolescent cannabis use
This study is looking at how cannabis use affects the brains of teenagers to find clues that could help create better treatments for those dealing with cannabis use issues.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Minnesota NIH-funded |
| Lab location | 1 site (Minneapolis, United States) |
| Project ID | NIH-10916449 on NIH RePORTER |
What this research studies
This research investigates the relationship between brain activity and cannabis use among adolescents, aiming to identify neural markers that could help in developing effective interventions. By utilizing advanced neuroimaging techniques like functional MRI (fMRI) and analyzing large datasets from studies such as the Adolescent Brain Cognitive Development (ABCD) study, the research seeks to clarify how these brain markers are influenced by cannabis use and other factors. The goal is to enhance treatment strategies for adolescents struggling with cannabis use disorder (CUD) by understanding the underlying neural mechanisms.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescents aged 12 to 21 who are experiencing issues related to cannabis use or are at risk for cannabis use disorder.
Not a fit: Patients who are not adolescents or those who do not use cannabis may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective interventions for adolescents with cannabis use disorder, improving their chances of sustained abstinence.
How similar studies have performed: Previous research using neuroimaging techniques has shown promise in understanding substance use disorders, indicating that this approach could yield valuable insights.
Where this research is happening
Minneapolis, United States
- University of Minnesota — Minneapolis, United States (Active)
Researchers
- Principal investigator: Tervo-Clemmens, Brenden Craig — University of Minnesota
- Study coordinator: Tervo-Clemmens, Brenden Craig
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.